{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T18:43:04Z","timestamp":1789411384455,"version":"build-2803163510"},"reference-count":61,"publisher":"MDPI AG","issue":"24","license":[{"start":{"date-parts":[[2022,12,16]],"date-time":"2022-12-16T00:00:00Z","timestamp":1671148800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004731","name":"Natural Science Foundation of Zhejiang Province","doi-asserted-by":"publisher","award":["LQ21H030002"],"award-info":[{"award-number":["LQ21H030002"]}],"id":[{"id":"10.13039\/501100004731","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004731","name":"Natural Science Foundation of Zhejiang Province","doi-asserted-by":"publisher","award":["215-432000282"],"award-info":[{"award-number":["215-432000282"]}],"id":[{"id":"10.13039\/501100004731","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004731","name":"Natural Science Foundation of Zhejiang Province","doi-asserted-by":"publisher","award":["215-432094250"],"award-info":[{"award-number":["215-432094250"]}],"id":[{"id":"10.13039\/501100004731","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Scientific Research Grant of Ningbo University","award":["LQ21H030002"],"award-info":[{"award-number":["LQ21H030002"]}]},{"name":"Scientific Research Grant of Ningbo University","award":["215-432000282"],"award-info":[{"award-number":["215-432000282"]}]},{"name":"Scientific Research Grant of Ningbo University","award":["215-432094250"],"award-info":[{"award-number":["215-432094250"]}]},{"name":"Ningbo Top Talent Project","award":["LQ21H030002"],"award-info":[{"award-number":["LQ21H030002"]}]},{"name":"Ningbo Top Talent Project","award":["215-432000282"],"award-info":[{"award-number":["215-432000282"]}]},{"name":"Ningbo Top Talent Project","award":["215-432094250"],"award-info":[{"award-number":["215-432094250"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJMS"],"abstract":"<jats:p>Liver fibrosis, a common liver dysfunction with high morbidity and mortality rates, is the leading cause of cirrhosis and hepatocellular carcinoma, for which there are no effective therapies. Ivermectin is an antiparasitic drug that also has been showing therapeutic actions in many other diseases, including antiviral and anticancer actions, as well as treating metabolic diseases. Herein, we evaluated the function of ivermectin in regulating liver fibrosis. Firstly, carbon tetrachloride (CCl4)-injected Balb\/c mice were used to assess the antifibrosis effects of ivermectin in vivo. Further, CFSC, a rat hepatic stellate cell (HSC) line, was used to explore the function of ivermectin in HSC activation in vitro. The in vivo data showed that ivermectin administration alleviated histopathological changes, improved liver function, reduced collagen deposition, and downregulated the expression of profibrotic genes. Mechanistically, the ivermectin treatment inhibited intrahepatic macrophage accumulation and suppressed the production of proinflammatory factors. Importantly, the ivermectin administration significantly decreased the protein levels of \u03b1-smooth muscle actin (\u03b1-SMA) both in vivo and in vitro, suggesting that the antifibrotic effects of ivermectin are mainly due to the promotion of HSC deactivation. The present study demonstrates that ivermectin may be a potential therapeutic agent for the prevention of hepatic fibrosis.<\/jats:p>","DOI":"10.3390\/ijms232416043","type":"journal-article","created":{"date-parts":[[2022,12,19]],"date-time":"2022-12-19T04:54:13Z","timestamp":1671425653000},"page":"16043","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Ivermectin Attenuates CCl4-Induced Liver Fibrosis in Mice by Suppressing Hepatic Stellate Cell Activation"],"prefix":"10.3390","volume":"23","author":[{"given":"Hanglu","family":"Ying","sequence":"first","affiliation":[{"name":"Institute of Drug Discovery Technology, Ningbo University, Ningbo 315211, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Long","family":"Li","sequence":"additional","affiliation":[{"name":"Institute of Drug Discovery Technology, Ningbo University, Ningbo 315211, China"},{"name":"Qian Xuesen Collaborative Research Center of Astrochemistry and Space Life Sciences, Ningbo University, Ningbo 315211, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yufen","family":"Zhao","sequence":"additional","affiliation":[{"name":"Institute of Drug Discovery Technology, Ningbo University, Ningbo 315211, China"},{"name":"Qian Xuesen Collaborative Research Center of Astrochemistry and Space Life Sciences, Ningbo University, Ningbo 315211, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Feng","family":"Ni","sequence":"additional","affiliation":[{"name":"Institute of Drug Discovery Technology, Ningbo University, Ningbo 315211, China"},{"name":"Qian Xuesen Collaborative Research Center of Astrochemistry and Space Life Sciences, Ningbo University, Ningbo 315211, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2022,12,16]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1038\/s41575-020-00372-7","article-title":"Molecular and cellular mechanisms of liver fibrosis and its regression","volume":"18","author":"Kisseleva","year":"2021","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"ref_2","doi-asserted-by":"crossref","unstructured":"Roehlen, N., Crouchet, E., and Baumert, T.F. (2020). Liver Fibrosis: Mechanistic Concepts and Therapeutic Perspectives. Cells, 9.","DOI":"10.3390\/cells9040875"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"671640","DOI":"10.3389\/fphar.2021.671640","article-title":"Cellular Mechanisms of Liver Fibrosis","volume":"12","author":"Acharya","year":"2021","journal-title":"Front. Pharmacol."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1177\/1535370219898141","article-title":"Mechanisms of liver fibrosis and its role in liver cancer","volume":"245","author":"Dhar","year":"2020","journal-title":"Exp. Biol. Med."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1016\/j.cmet.2020.10.026","article-title":"The Power of Plasticity-Metabolic Regulation of Hepatic Stellate Cells","volume":"33","author":"Trivedi","year":"2021","journal-title":"Cell Metab."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"1825","DOI":"10.1113\/JP281061","article-title":"Hepatic stellate cells in physiology and pathology","volume":"600","author":"Kamm","year":"2022","journal-title":"J. Physiol."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"730176","DOI":"10.3389\/fcell.2021.730176","article-title":"Liver Fibrosis: Therapeutic Targets and Advances in Drug Therapy","volume":"9","author":"Tan","year":"2021","journal-title":"Front. Cell Dev. Biol."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1038\/s41392-022-01070-3","article-title":"Targeting fibrosis, mechanisms and cilinical trials","volume":"7","author":"Zhao","year":"2022","journal-title":"Signal Transduct. Target. Ther."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.ijantimicag.2019.05.003","article-title":"Ivermectin: From theory to clinical application","volume":"54","author":"Ashour","year":"2019","journal-title":"Int. J. Antimicrob. Agents"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.pt.2020.10.005","article-title":"Ivermectin: An Anthelmintic, an Insecticide, and Much More","volume":"37","author":"Martin","year":"2021","journal-title":"Trends Parasitol."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1016\/j.pt.2017.02.004","article-title":"Ivermectin\u2014Old Drug, New Tricks?","volume":"33","author":"Laing","year":"2017","journal-title":"Trends Parasitol."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.14202\/vetworld.2019.1204-1211","article-title":"Current therapeutic applications and pharmacokinetic modulations of ivermectin","volume":"12","author":"Sharun","year":"2019","journal-title":"Vet. World"},{"key":"ref_13","first-page":"589","article-title":"Anti-inflammatory effects of ivermectin in mouse model of allergic asthma","volume":"60","author":"Yan","year":"2011","journal-title":"Inflamm. Res. Off. J. Eur. Histamine Res. Soc."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"1937","DOI":"10.1038\/ncomms2924","article-title":"The antiparasitic drug ivermectin is a novel FXR ligand that regulates metabolism","volume":"4","author":"Jin","year":"2013","journal-title":"Nat. Commun."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"105207","DOI":"10.1016\/j.phrs.2020.105207","article-title":"Ivermectin, a potential anticancer drug derived from an antiparasitic drug","volume":"163","author":"Tang","year":"2021","journal-title":"Pharmacol. Res."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"104787","DOI":"10.1016\/j.antiviral.2020.104787","article-title":"The FDA-approved drug ivermectin inhibits the replication of SARS-CoV-2 in vitro","volume":"178","author":"Caly","year":"2020","journal-title":"Antiviral Res."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"104760","DOI":"10.1016\/j.antiviral.2020.104760","article-title":"The broad spectrum antiviral ivermectin targets the host nuclear transport importin alpha\/beta1 heterodimer","volume":"177","author":"Yang","year":"2020","journal-title":"Antiviral Res."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"1884","DOI":"10.1093\/jac\/dks147","article-title":"Ivermectin is a potent inhibitor of flavivirus replication specifically targeting NS3 helicase activity: New prospects for an old drug","volume":"67","author":"Mastrangelo","year":"2012","journal-title":"J. Antimicrob. Chemother."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"3593","DOI":"10.1182\/blood-2010-01-262675","article-title":"The antiparasitic agent ivermectin induces chloride-dependent membrane hyperpolarization and cell death in leukemia cells","volume":"116","author":"Sharmeen","year":"2010","journal-title":"Blood"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"5387","DOI":"10.1111\/jcmm.15195","article-title":"Ivermectin suppresses tumour growth and metastasis through degradation of PAK1 in oesophageal squamous cell carcinoma","volume":"24","author":"Chen","year":"2020","journal-title":"J. Cell. Mol. Med."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"1702","DOI":"10.1002\/jcb.27490","article-title":"Suppressing ROS-TFE3-dependent autophagy enhances ivermectin-induced apoptosis in human melanoma cells","volume":"120","author":"Deng","year":"2018","journal-title":"J. Cell. Biochem."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"4457","DOI":"10.1158\/0008-5472.CAN-15-2887","article-title":"Ivermectin Induces Cytostatic Autophagy by Blocking the PAK1\/Akt Axis in Breast Cancer","volume":"76","author":"Dou","year":"2016","journal-title":"Cancer Res."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"1","DOI":"10.4254\/wjh.v10.i1.1","article-title":"Role of inflammatory response in liver diseases: Therapeutic strategies","volume":"10","author":"Gallego","year":"2018","journal-title":"World J. Hepatol."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"17288","DOI":"10.1038\/srep17288","article-title":"Selective targeting of nuclear receptor FXR by avermectin analogues with therapeutic effects on nonalcoholic fatty liver disease","volume":"5","author":"Jin","year":"2015","journal-title":"Sci. Rep."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1016\/j.fct.2019.02.005","article-title":"Permethrin and ivermectin modulate lipid metabolism in steatosis-induced HepG2 hepatocyte","volume":"125","author":"Yang","year":"2019","journal-title":"Food Chem. Toxicol. Int. J. Publ. Br. Ind. Biol. Res. Assoc."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"2279","DOI":"10.1111\/liv.14940","article-title":"Hepatic macrophages: Key players in the development and progression of liver fibrosis","volume":"41","author":"Cheng","year":"2021","journal-title":"Liver Int."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1016\/j.jconrel.2020.10.009","article-title":"Ivermectin: An award-winning drug with expected antiviral activity against COVID-19","volume":"329","author":"Formiga","year":"2021","journal-title":"J. Control. Release"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"2959","DOI":"10.1002\/jcp.30055","article-title":"Quantitative proteomics reveals a broad-spectrum antiviral property of ivermectin, benefiting for COVID-19 treatment","volume":"236","author":"Li","year":"2021","journal-title":"J. Cell. Physiol."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"e001350","DOI":"10.1136\/openhrt-2020-001350","article-title":"Ivermectin may be a clinically useful anti-inflammatory agent for late-stage COVID-19","volume":"7","author":"DiNicolantonio","year":"2020","journal-title":"Open Heart"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"1549","DOI":"10.1016\/j.bmcl.2019.04.045","article-title":"Doxycycline, salinomycin, monensin and ivermectin repositioned as cancer drugs","volume":"29","author":"Markowska","year":"2019","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"ref_31","doi-asserted-by":"crossref","unstructured":"Di Paola, R., Modafferi, S., Siracusa, R., Cordaro, M., D\u2032Amico, R., Ontario, M.L., Interdonato, L., Salinaro, A.T., Fusco, R., and Impellizzeri, D. (2022). S-Acetyl-Glutathione Attenuates Carbon Tetrachloride-Induced Liver Injury by Modulating Oxidative Imbalance and Inflammation. Int. J. Mol. Sci., 23.","DOI":"10.3390\/ijms23084429"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1016\/j.matbio.2018.04.006","article-title":"Liver fibrosis: Direct antifibrotic agents and targeted therapies","volume":"68\u201369","author":"Schuppan","year":"2018","journal-title":"Matrix Biol."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"e6645","DOI":"10.7717\/peerj.6645","article-title":"Identification of key genes, pathways and potential therapeutic agents for liver fibrosis using an integrated bioinformatics analysis","volume":"7","author":"Zhan","year":"2019","journal-title":"PeerJ"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.matbio.2018.03.007","article-title":"Connective tissue growth factor (CTGF) from basics to clinics","volume":"68\u201369","author":"Ramazani","year":"2018","journal-title":"Matrix Biol."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.bbrc.2022.01.094","article-title":"Key genes in the liver fibrosis process are mined based on single-cell transcriptomics","volume":"598","author":"Ai","year":"2022","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/j.dld.2004.11.009","article-title":"Alpha-SMA expression in hepatic stellate cells and quantitative analysis of hepatic fibrosis in cirrhosis and in recurrent chronic hepatitis after liver transplantation","volume":"37","author":"Carpino","year":"2005","journal-title":"Dig. Liver Dis."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1016\/j.drudis.2021.12.012","article-title":"Therapeutic potential of targeting regulatory mechanisms of hepatic stellate cell activation in liver fibrosis","volume":"27","author":"Baghaei","year":"2022","journal-title":"Drug Discov. Today"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1038\/nrgastro.2017.38","article-title":"Mechanisms of hepatic stellate cell activation","volume":"14","author":"Tsuchida","year":"2017","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"2219","DOI":"10.1111\/febs.13665","article-title":"TGF-beta signalling and liver disease","volume":"283","author":"Fabregat","year":"2016","journal-title":"FEBS J."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1186\/s12974-019-1455-y","article-title":"Elevated circulating TGFbeta1 during acute liver failure activates TGFbetaR2 on cortical neurons and exacerbates neuroinflammation and hepatic encephalopathy in mice","volume":"16","author":"McMillin","year":"2019","journal-title":"J. Neuroinflamm."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1007\/s12026-022-09267-y","article-title":"Research progress on drugs targeting the TGF-beta signaling pathway in fibrotic diseases","volume":"70","author":"Shi","year":"2022","journal-title":"Immunol. Res."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.matbio.2017.12.016","article-title":"Targeting TGF-beta signaling for the treatment of fibrosis","volume":"68\u201369","author":"Gyorfi","year":"2018","journal-title":"Matrix Biol."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1007\/s00436-021-07064-4","article-title":"Effect of macrocyclic lactones on nontarget coprophilic organisms: A review","volume":"120","author":"Junco","year":"2021","journal-title":"Parasitol. Res."},{"key":"ref_44","doi-asserted-by":"crossref","unstructured":"Munoz-Munoz, L., Shoen, C., Sweet, G., Vitoria, A., Bull, T.J., Cynamon, M., Thompson, C.J., and Ramon-Garcia, S. (2021). Repurposing Avermectins and Milbemycins against Mycobacteroides abscessus and Other Nontuberculous Mycobacteria. Antibiotics, 10.","DOI":"10.3390\/antibiotics10040381"},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"105010","DOI":"10.1016\/j.pestbp.2021.105010","article-title":"The avermectin\/milbemycin receptors of parasitic nematodes","volume":"181","author":"Wolstenholme","year":"2022","journal-title":"Pestic. Biochem. Physiol."},{"key":"ref_46","doi-asserted-by":"crossref","unstructured":"El-Saber Batiha, G., Alqahtani, A., Ilesanmi, O.B., Saati, A.A., El-Mleeh, A., Hetta, H.F., and Magdy Beshbishy, A. (2020). Avermectin Derivatives, Pharmacokinetics, Therapeutic and Toxic Dosages, Mechanism of Action, and Their Biological Effects. Pharmaceuticals, 13.","DOI":"10.3390\/ph13080196"},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"853","DOI":"10.2174\/138920112800399095","article-title":"History of avermectin and ivermectin, with notes on the history of other macrocyclic lactone antiparasitic agents","volume":"13","author":"Campbell","year":"2012","journal-title":"Curr. Pharm. Biotechnol."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1016\/j.cvsm.2018.07.002","article-title":"Toxicology of Avermectins and Milbemycins (Macrocyclic Lactones) and the Role of P-Glycoprotein in Dogs and Cats","volume":"48","author":"Merola","year":"2018","journal-title":"Vet. Clin. N. Am. Small Anim. Pract."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"166133","DOI":"10.1016\/j.bbadis.2021.166133","article-title":"FXR in liver physiology: Multiple faces to regulate liver metabolism","volume":"1867","author":"Panzitt","year":"2021","journal-title":"Biochim. Biophys. Acta Mol. Basis Dis."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1038\/s41575-020-00404-2","article-title":"The role of farnesoid X receptor in metabolic diseases, and gastrointestinal and liver cancer","volume":"18","author":"Sun","year":"2021","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"2148","DOI":"10.1016\/j.csbj.2021.04.029","article-title":"Farnesoid X receptor (FXR): Structures and ligands","volume":"19","author":"Jiang","year":"2021","journal-title":"Comput. Struct. Biotechnol. J."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"1829","DOI":"10.1007\/s00204-022-03266-6","article-title":"Farnesoid X receptor (FXR) agonists induce hepatocellular apoptosis and impair hepatic functions via FXR\/SHP pathway","volume":"96","author":"Zhang","year":"2022","journal-title":"Arch. Toxicol."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"1497","DOI":"10.1053\/j.gastro.2004.08.001","article-title":"The nuclear receptor SHP mediates inhibition of hepatic stellate cells by FXR and protects against liver fibrosis","volume":"127","author":"Fiorucci","year":"2004","journal-title":"Gastroenterology"},{"key":"ref_54","doi-asserted-by":"crossref","unstructured":"Ramos-Tovar, E., and Muriel, P. (2020). Molecular Mechanisms That Link Oxidative Stress, Inflammation, and Fibrosis in the Liver. Antioxidants, 9.","DOI":"10.3390\/antiox9121279"},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1002\/hep.27332","article-title":"Hepatic inflammation and fibrosis: Functional links and key pathways","volume":"61","author":"Seki","year":"2015","journal-title":"Hepatology"},{"key":"ref_56","doi-asserted-by":"crossref","unstructured":"Binatti, E., Gerussi, A., Barisani, D., and Invernizzi, P. (2022). The Role of Macrophages in Liver Fibrosis: New Therapeutic Opportunities. Int. J. Mol. Sci., 23.","DOI":"10.3390\/ijms23126649"},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1038\/s41423-020-00558-8","article-title":"Hepatic macrophages in liver homeostasis and diseases-diversity, plasticity and therapeutic opportunities","volume":"18","author":"Wen","year":"2021","journal-title":"Cell. Mol. Immunol."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"354","DOI":"10.3389\/fimmu.2020.00354","article-title":"Systemic MCP-1 Levels Derive Mainly from Injured Liver and Are Associated with Complications in Cirrhosis","volume":"11","author":"Queck","year":"2020","journal-title":"Front. Immunol."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.livres.2020.01.002","article-title":"Functional roles of CCL5\/RANTES in liver disease","volume":"4","author":"Chen","year":"2020","journal-title":"Liver Res."},{"key":"ref_60","first-page":"524","article-title":"Ivermectin inhibits LPS-induced production of inflammatory cytokines and improves LPS-induced survival in mice","volume":"57","author":"Zhang","year":"2008","journal-title":"Inflamm. Res. Off. J. Eur. Histamine Res. Soc."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1136\/gutjnl-2020-323345","article-title":"Sodium(+)\/taurocholate cotransporting polypeptide as target therapy for liver fibrosis","volume":"71","author":"Salhab","year":"2022","journal-title":"Gut"}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/23\/24\/16043\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T01:42:44Z","timestamp":1760146964000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/23\/24\/16043"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12,16]]},"references-count":61,"journal-issue":{"issue":"24","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["ijms232416043"],"URL":"https:\/\/doi.org\/10.3390\/ijms232416043","relation":{},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,12,16]]}}}